Carol A. Sartorius

5.4k total citations
76 papers, 3.7k citations indexed

About

Carol A. Sartorius is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Carol A. Sartorius has authored 76 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 39 papers in Genetics and 29 papers in Molecular Biology. Recurrent topics in Carol A. Sartorius's work include Estrogen and related hormone effects (39 papers), Cancer Cells and Metastasis (31 papers) and Breast Cancer Treatment Studies (11 papers). Carol A. Sartorius is often cited by papers focused on Estrogen and related hormone effects (39 papers), Cancer Cells and Metastasis (31 papers) and Breast Cancer Treatment Studies (11 papers). Carol A. Sartorius collaborates with scholars based in United States, Canada and Australia. Carol A. Sartorius's co-authors include Kathryn B. Horwitz, Lin Tung, Glenn S. Takimoto, Peter Kabos, Jessica Finlay-Schultz, J. Chuck Harrell, Wendy W. Dye, Britta M. Jacobsen, Leslie A. Leinwand and Jennifer K. Richer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Carol A. Sartorius

74 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol A. Sartorius United States 39 1.8k 1.6k 1.5k 892 454 76 3.7k
James DiRenzo United States 26 3.7k 2.0× 1.7k 1.1× 1.4k 0.9× 949 1.1× 346 0.8× 41 4.8k
Sophie Vacher France 39 2.6k 1.4× 448 0.3× 1.5k 1.0× 1.5k 1.6× 429 0.9× 142 4.5k
Ciro Abbondanza Italy 24 1.9k 1.0× 1.0k 0.6× 511 0.3× 344 0.4× 184 0.4× 56 2.7k
Ken‐ichi Takayama Japan 36 2.3k 1.3× 531 0.3× 446 0.3× 1.4k 1.6× 409 0.9× 90 3.6k
Laura Rosanò Italy 35 2.1k 1.1× 250 0.2× 915 0.6× 671 0.8× 357 0.8× 63 3.7k
Valeriana Di Castro Italy 33 2.0k 1.1× 257 0.2× 833 0.6× 641 0.7× 321 0.7× 56 3.5k
Shlomit Halachmi Israel 14 2.3k 1.3× 1.2k 0.7× 1.3k 0.9× 408 0.5× 305 0.7× 28 3.4k
Maty Tzukerman Israel 28 2.4k 1.3× 1.4k 0.9× 562 0.4× 296 0.3× 302 0.7× 46 3.6k
Qianben Wang United States 37 4.6k 2.5× 1.7k 1.0× 849 0.6× 1.3k 1.5× 318 0.7× 67 6.1k
Steven A. Johnsen Germany 42 3.8k 2.1× 617 0.4× 1.3k 0.9× 635 0.7× 318 0.7× 106 4.9k

Countries citing papers authored by Carol A. Sartorius

Since Specialization
Citations

This map shows the geographic impact of Carol A. Sartorius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol A. Sartorius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol A. Sartorius more than expected).

Fields of papers citing papers by Carol A. Sartorius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol A. Sartorius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol A. Sartorius. The network helps show where Carol A. Sartorius may publish in the future.

Co-authorship network of co-authors of Carol A. Sartorius

This figure shows the co-authorship network connecting the top 25 collaborators of Carol A. Sartorius. A scholar is included among the top collaborators of Carol A. Sartorius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol A. Sartorius. Carol A. Sartorius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Finlay-Schultz, Jessica, Heather M. Brechbuhl, Andrew E. Libby, et al.. (2025). Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells. Breast Cancer Research. 27(1). 32–32. 2 indexed citations
2.
Cain, Derek W., John A. Cidlowski, Dean P. Edwards, et al.. (2023). 3C. 3-Ketosteroid receptors in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE. 2023(1). 1 indexed citations
3.
Turner, Scott A., Andrea Ferreira‐Gonzalez, Amy L. Olex, et al.. (2023). Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer. Cancers. 15(12). 3179–3179. 3 indexed citations
4.
McGinn, Olivia, et al.. (2022). Cytokeratins 5 and 17 Maintain an Aggressive Epithelial State in Basal-Like Breast Cancer. Molecular Cancer Research. 20(9). 1443–1455. 11 indexed citations
5.
Sartorius, Carol A., et al.. (2022). Transcription factor–nucleosome dynamics from plasma cfDNA identifies ER-driven states in breast cancer. Science Advances. 8(34). eabm4358–eabm4358. 13 indexed citations
6.
Brechbuhl, Heather M., Mengyu Xie, Kiran Paul, et al.. (2021). Neoadjuvant endocrine therapy expands stromal populations that predict poor prognosis in estrogen receptor‐positive breast cancer. Molecular Carcinogenesis. 61(3). 359–371. 5 indexed citations
7.
Brechbuhl, Heather M., Kiran Paul, Austin E. Gillen, et al.. (2020). Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells. Molecular Carcinogenesis. 59(10). 1129–1139. 32 indexed citations
8.
Wahdan-Alaswad, Reema S., Susan M. Edgerton, Hyunmin Kim, et al.. (2020). Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor–Positive Breast Cancers. Clinical Cancer Research. 27(2). 585–597. 10 indexed citations
9.
Dalotto‐Moreno, Tomás, Silvia I. Vanzulli, Derek C. Radisky, et al.. (2020). Enhanced Antitumor Immunity via Endocrine Therapy Prevents Mammary Tumor Relapse and Increases Immune Checkpoint Blockade Sensitivity. Cancer Research. 81(5). 1375–1387. 25 indexed citations
10.
Finlay-Schultz, Jessica, Britta M. Jacobsen, Kiran Paul, et al.. (2020). New generation breast cancer cell lines developed from patient-derived xenografts. Breast Cancer Research. 22(1). 68–68. 30 indexed citations
11.
McGinn, Olivia, et al.. (2020). Cytokeratin 5 alters β-catenin dynamics in breast cancer cells. Oncogene. 39(12). 2478–2492. 22 indexed citations
12.
Riemondy, Kent, Monica Ransom, Christopher P Alderman, et al.. (2018). Recovery and analysis of transcriptome subsets from pooled single-cell RNA-seq libraries. Nucleic Acids Research. 47(4). e20–e20. 14 indexed citations
13.
Brechbuhl, Heather M., Jessica Finlay-Schultz, Tomomi M. Yamamoto, et al.. (2016). Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen. Clinical Cancer Research. 23(7). 1710–1721. 164 indexed citations
14.
Wellberg, Elizabeth A., Jessica Finlay-Schultz, Andrew Lewis, et al.. (2016). The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis. Breast Cancer Research. 18(1). 131–131. 47 indexed citations
15.
Tentler, John J., Aik Choon Tan, Todd M. Pitts, et al.. (2015). p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 14(5). 1117–1129. 39 indexed citations
16.
Kabos, Peter, Jessica Finlay-Schultz, Chunling Li, et al.. (2012). Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures. Breast Cancer Research and Treatment. 135(2). 415–432. 98 indexed citations
17.
Spillman, Monique A., Nicole Manning, Wendy W. Dye, et al.. (2010). Tissue-Specific Pathways for Estrogen Regulation of Ovarian Cancer Growth and Metastasis. Cancer Research. 70(21). 8927–8936. 53 indexed citations
18.
Cittelly, Diana M., Jennifer K. Richer, & Carol A. Sartorius. (2010). Ovarian steroid hormones: what's hot in the stem cell pool?. Breast Cancer Research. 12(4). 309–309.
19.
Harrell, J. Chuck, Wendy W. Dye, Djuana M. E. Harvell, et al.. (2007). Estrogen Insensitivity in a Model of Estrogen Receptor–Positive Breast Cancer Lymph Node Metastasis. Cancer Research. 67(21). 10582–10591. 39 indexed citations
20.
Jacobsen, Britta M., Jennifer K. Richer, Carol A. Sartorius, & Kathryn B. Horwitz. (2003). Expression Profiling of Human Breast Cancers and Gene Regulation by Progesterone Receptors. Journal of Mammary Gland Biology and Neoplasia. 8(3). 257–268. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James DiRenzo Breakdown of academic impact, for papers by Sophie Vacher Breakdown of academic impact, for papers by Ciro Abbondanza Breakdown of academic impact, for papers by Ken‐ichi Takayama Breakdown of academic impact, for papers by Laura Rosanò Breakdown of academic impact, for papers by Valeriana Di Castro Breakdown of academic impact, for papers by Shlomit Halachmi Breakdown of academic impact, for papers by Maty Tzukerman Breakdown of academic impact, for papers by Qianben Wang Breakdown of academic impact, for papers by Steven A. Johnsen
Rankless by CCL
2026